|
Volumn 18, Issue 5, 2000, Pages 451-457
|
Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme: A Canadian teaching hospital and ministry of health perspective
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPHOTERICIN B;
AMPICILLIN;
ANTIBIOTIC AGENT;
CEFAZOLIN;
CEFTAZIDIME;
CEFTIZOXIME;
CEFTRIAXONE;
CLINDAMYCIN;
CLOXACILLIN;
FOSCARNET;
GENTAMICIN;
PENICILLIN G;
PIPERACILLIN;
VANCOMYCIN;
ADULT;
ANTIBIOTIC THERAPY;
ARTICLE;
BONE INFECTION;
CANADA;
COST BENEFIT ANALYSIS;
COST MINIMIZATION ANALYSIS;
COST OF ILLNESS;
DRUG COST;
ENDOCARDITIS;
HEALTH CARE FINANCING;
HEALTH PROGRAM;
HOSPITALIZATION;
HUMAN;
INFECTION;
INFECTIOUS ARTHRITIS;
LENGTH OF STAY;
MAJOR CLINICAL STUDY;
OUTPATIENT CARE;
PRIORITY JOURNAL;
RESPIRATORY TRACT INFECTION;
SKIN INFECTION;
SOFT TISSUE INFECTION;
TREATMENT OUTCOME;
|
EID: 0033773299
PISSN: 11707690
EISSN: None
Source Type: Journal
DOI: 10.2165/00019053-200018050-00004 Document Type: Article |
Times cited : (87)
|
References (16)
|